Local and Systemic IKK<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mo mathvariant="bold">ε</mml:mo></mml:mrow></mml:math>and NF-<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M2"><mml:mrow><mml:mo mathvariant="bold">κ</mml:mo></mml:mrow></mml:math>B Signaling Associated with Sjögren’s Syndrome Immunopathogenesis
Weiqian Chen(First Affiliated Hospital Zhejiang University), Wenbin Qian(Ministry of Education of the People's Republic of China)
Cited by 22
Related Papers
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
|The Lancet Haematology|2019|248
Genomic and Transcriptomic Characterization of Natural Killer T Cell Lymphoma
|Cancer Cell|2020|234
Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo
|Journal of Experimental & Clinical Cancer Research|2018|86
Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells
|International Journal of Oncology|2016|42